Mixed amphetamine salts (extended-release)
آمفتامین (نمکهای ترکیبی، آهستهرهش)
🧠 Nervous SystemCNS stimulant
Market / country: 🇺🇸 USA
Adderall XR (US)
🧮 Dose calculator
Attention-deficit/hyperactivity disorder · Regimen source: FDA Adderall XR · 2.3
- • Screen for cardiac disease and tics first. Swallow whole or sprinkle on applesauce. FDA Adderall XR · 2.1FDA Adderall XR · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to amphetamine; MAOIs concomitantly or within 14 days (hypertensive crisis). FDA Adderall XR · 4
Warnings
- • Boxed warning: high potential for abuse, misuse and addiction, overdose and death. FDA Adderall XR · Boxed Warning
- • Risk in serious cardiac disease; raised BP and HR; psychiatric reactions; growth suppression; seizures; Raynaud; serotonin syndrome; tics. FDA Adderall XR · 5
Renal adjustment
- • eGFR < 30: GFR 15–<30: adults 15 mg, children 5 mg (6–12 y max 20); ESRD not recommended. FDA Adderall XR · 2.6
Formulations
- 10 mg XR capsule — capsule 🇺🇸 USA FDA Adderall XR · 3
- 20 mg XR capsule — capsule 🇺🇸 USA FDA Adderall XR · 3
- 5 mg XR capsule — capsule 🇺🇸 USA FDA Adderall XR · 3
- 30 mg XR capsule — capsule 🇺🇸 USA FDA Adderall XR · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Adderall XR · 8.1
“Risk Summary Available data from published epidemiologic studies and postmarketing reports on use of prescription amphetamine in pregnant women have not identified a drug-associated risk of major birth defects and miscarriage (see Data ) .”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Adderall XR · 8.2
“Because of the potential for serious adverse reactions in nursing infants, advise patients that breastfeeding is not recommended during treatment with ADDERALL XR.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Adderall XR · 8.4
“The safety and effectiveness of ADDERALL XR have been established in pediatric patients with ADHD 6 years of age and older.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Adderall XR · 8.5
“ADDERALL XR has not been studied in the geriatric population.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021303
- DailyMed (FDA label)FDA Adderall XR
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDN06BA01
- Darooyab (Iran)Amfetamine
🇮🇷 Not found in Iran list Darooyab · G-3363/Amfetamine
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Adderall XR · 3FDA Adderall XR · 2.3FDA Adderall XR · 2.1FDA Adderall XR · 2.2FDA Adderall XR · 2.4FDA Adderall XR · 2.5FDA Adderall XR · 4FDA Adderall XR · Boxed WarningFDA Adderall XR · 5FDA Adderall XR · 2.6FDA Adderall XR · 8.1FDA Adderall XR · 8.2FDA Adderall XR · 8.4FDA Adderall XR · 8.5FDA Adderall XR · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3363/Amfetamine
- Clinical review⚠ Unverified